County Durham man first in England to benefit from new drug
A County Durham man is one of the first patients in England to benefit from a new Parkinson's disease treatment.
Anthony Quinn, a patient at County Durham and Darlington NHS Foundation Trust, is being treated with a new drug called Produodopa.
This is a combination of levodopa and foscarbidopa, which is given to patients through a small pump that delivers the medication continuously under the skin for over 24 hours.
The new treatment reduces the need for multiple daily tablets and can improve motor symptoms, energy levels, and overall quality of life for Parkinson's disease patients.
Since starting the treatment, Mr Quinn has said he now enjoys activities that were previously out of reach, such as three-mile bike rides and late-night gaming sessions.
(Image: Supplied) He said: "This new treatment has given me a new lease of life.
"I can now do things that weren't possible before, like riding my bike and playing video games.
"Even simple everyday tasks have become easier.
"It really has changed my life."
The County Durham and Darlington NHS Foundation Trust is the first acute trust outside of a neuroscience centre to administer the treatment, which is aimed at helping people with the fastest-growing neurological condition worldwide.
Jeremy Cundall, executive medical director at County Durham and Darlington NHS Foundation Trust, said: "It is fantastic that our Movement Disorder Team have introduced this groundbreaking therapy, which can profoundly improve the quality of life for patients like Anthony.
"Being at the forefront of this new drug, as the first acute trust outside of a neuroscience centre, is a testament to the dedication and innovation of the team.
"As a trust, we are committed to delivering cutting-edge, high-quality care that can improve outcomes and make a positive difference in the lives of our patients and the communities we serve."
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
3 hours ago
- Yahoo
Aspen Neuroscience to Present at the International Society for Stem Cell Research (ISSCR) 2025 Annual Meeting
Presentation of Data from Clinical Trial of Aspen's Autologous iPSC-derived Approach for Neuronal Replacement Therapy in Parkinson's Disease SAN DIEGO, June 9, 2025 /PRNewswire/ -- Aspen Neuroscience, Inc. announced its participation in "Illuminating the Future," the International Society for Stem Cell Research (ISSCR) 2025 Annual Meeting, to be held in Hong Kong June 11-14. Aspen Co-founder and Senior Vice President, Research and Development, Andrés Bratt-Leal, PhD will deliver a presentation, Safety, tolerability, and efficacy of transplanted autologous iPSC-derived dopaminergic precursors in moderate to advanced Parkinson's Disease. Dr. Bratt-Leal's presentation will cover data for the first four patients of the ASPIRO Study*, a Phase 1/2a trial of the company's iPSC-derived autologous cell therapy (ANPD001). The open label trial was designed to evaluate the safety, tolerability and efficacy of intracranial implantation of autologous induced pluripotent stem cell (iPSC)-derived dopaminergic neuronal precursor cells (DANPCs) in patients with moderate to advanced Parkinson's disease. The primary objective of the ongoing study is to assess safety and tolerability of the procedure. A secondary objective is to evaluate clinical efficacy as measured by change from baseline in multiple patient-reported and clinician-reported Parkinson's disease outcome measures. Continued follow up and evaluation of a higher-dose cohort in the study are ongoing. "Early data from the first four patients show that precision intracranial delivery of DANPCs is safe and well-tolerated," reported Dr. Bratt-Leal. "Both patient-reported and clinician-reported outcomes show early signs of changes from baseline in multiple clinically meaningful outcome measures. Autologous iPSC-derived therapy as a regenerative medicine approach has the unique advantage of not requiring immunosuppressive medications." About Aspen Neuroscience Headquartered in San Diego, Aspen Neuroscience, Inc. is a clinical development-stage, private company focused on autologous regenerative medicine. The company's patient-derived iPSC platform is used to create personalized therapies to address diseases with high unmet medical needs, beginning with autologous neuron replacement for PD. Aspen combines cell biology with the latest machine learning and genomic approaches to investigate patient-specific, restorative cell treatments. The company has developed a best-in-class platform to create and optimize pluripotent-derived cell therapies, which includes in-house bioinformatics, manufacturing and quality control. For more information and important updates, please visit or email media@ * The study was made possible by funding from the California Institute for Regenerative Medicine (CIRM), a state of California Agency that funds regenerative medicine, stem cell, and gene therapy research (Grant Number CLIN2-15547). View original content to download multimedia: SOURCE Aspen Neuroscience, Inc. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
New York Post
16 hours ago
- New York Post
Simple tool could detect Parkinson's disease early — it was 96% accurate in experiments
This pen truly is mightier than the sword. A team of researchers at UCLA has developed a high-tech diagnostic pen that can detect signs of Parkinson's disease with over 96% accuracy, offering a low-cost way to identify the neurodegenerative disorder far earlier than now. A pilot study in the journal Nature Chemical Engineering unveiled the device, which looks much like a regular pen. 3 A patient with PD using the diagnostic pen for a writing task. Nature Chemical Engineering It's able pick up on subtle motor dysfunctions before they're visible to the naked eye, all by analyzing how people write. So, how does this futuristic fountain pen work? The tip is made of a flexible silicone material infused with magnetic particles, and it writes using a special ferrofluid ink that contains nanomagnets. As someone writes, pressure from the hand deforms the tip, causing changes in magnetic fields that produce electrical signals — like a Morse code of motor function. Those signals are then analyzed to detect the difference between healthy and Parkinson's-affected motor patterns. In tests with 16 participants — including 3 with Parkinson's — the system nailed the diagnosis with 96.22% accuracy. Even more impressive? The pen worked whether people wrote on paper or in the air, meaning it doesn't even require a surface. 3 Nature Chemical Engineering Today, Parkinson's is largely diagnosed based on observations, which are subjective, or by biomarker-based imaging, which can be expensive. This diagnostic pen is portable, inexpensive and doesn't rely on a neurologist to interpret results, making it a promising option for remote screenings, home use or even telehealth checkups. 'Our development of the diagnostic pen represents a low-cost, widely disseminable and reliable technology with the potential to improve PD diagnostics across large populations and resource-limited areas,' the researchers wrote. With further validation in a larger population, the device could be used not just for early diagnosis, but for ongoing symptom tracking and personalized treatment monitoring. 3 Today, Parkinson's is largely diagnosed based on observations, which are subjective, or by biomarker-based imaging, which can be expensive. highwaystarz – This is just the latest innovation aimed at tackling Parkinson's disease, which affects more than 10 million people worldwide and has no known cure. A recent study found that psilocybin — the psychedelic compound that gave 'magic mushrooms' their trippy reputation in the 1960s — showed serious promise for improving mood and motor function in people with Parkinson's disease. Tavapadon — a new drug that mimics dopamine by targeting certain receptors — has also shown promise in clinical trials by reducing motor fluctuations and maintaining symptom control with fewer side effects than traditional therapies. Produodopa — a continuous infusion therapy first administered in the UK — was approved by the US Food and Drug Administration last fall. Innovative approaches targeting the psychological aspects of the disease have been successful as well — with tandem cycling proving to be especially popular. Some New Yorkers even find relief by playing pingpong.
Los Angeles Times
a day ago
- Los Angeles Times
Fighting Parkinson's one punch at a time
They pull giant boxing gloves over aging, sometimes shaking hands. They approach a black punching bag on weary, sometimes wobbly feet. Then they wail. Lord, do they wail. They hit the bag with a left-handed jab, a right-handed reverse, a hook, another hook, an uppercut, another jab, bam, bam, bam. They end the flurry with kicks, side kicks, thrust kicks, wild kicks, their legs suddenly strong and purposeful and fueled by a strength that once seemed impossible. Outside of this small gym in a nondescript office park in Monrovia, they are elderly people dealing with the motion-melting nightmare that is Parkinson's disease. But inside the walls of Kaizen Martial Arts & Fitness, in a program known as Kaizen Kinetics, they are heavyweight champs. Ranging in age from 50 to 90, spanning the spectrum of swift strides to wheelchairs, they are the most courageous athletes I've met. They show up here every couple of days hoping that they'll move enough to keep the evil Parky at bay. They're trying to punch him out, kick him off, scare him away, and they'll endure more than an hour of sometimes painful exercise to make this happen. They are frail women screaming, 'Jab!' and shaky men screaming, 'Hook!' and everyone counting with clenched teeth through 75 minutes that stretch the shrinking muscles and test the weary optimism. I am in awe of them, perhaps because I am one of them. I, too, am living with Parkinson's disease. The irony, huh? I've spent my entire career writing triumphant stories about athletes overcoming illness and adversity, only to reach the home stretch struggling to find a similar triumph in a story about me. It's not easy. Now I know what all those subjects of all those feel-good stories understood about the truth behind my positive prose. Degenerative disease sucks beyond any inspirational adjective. Incurable illness stinks beyond any hopeful headline. I've got Parkinson's, and it hurts to even say it. I'm still mobile, still active, I don't have the trademark tremors that distinguish the famously afflicted Michael J. Fox or the late Muhammad Ali but, damn it, I've got it. I was diagnosed four years ago after complaining of weakness in my right arm. That weakness has disappeared, but it's a constant struggle to keep everything else from slowly going to hell. Every day it feels like I've just run a marathon. I move well, my balance is fine, but I'm always tight, always creaking. The amount of medication required to keep me active is so immense, my pills come in gallon jugs and I spend entire Dodger games trying to discreetly swallow them in the press box. I move slower now. My fiancee Roxana qualifies for sainthood because whenever we go out, she must patiently wait for me to get dressed, which takes forever and is accompanied by the unholy sounds of struggle. I don't smile as much now. It's harder to smile when afflicted with the trademark Parkinson's masked face. When I FaceTime with my darling Daisy, I worry she won't see past my dour expression and never know how much her granddaddy loves her. Until now, my condition has only been known to my family. Not even my bosses knew. I didn't look like Parky, I didn't act like Parky, so why should I publicly reveal something so personal and embarrassing? Yeah, I was embarrassed. I felt humiliated in a way that made no sense and total sense. To me, Parkinson's implies frailty, Parkinson's implies weakness. But let me tell you, a 72-year-old woman pounding the living hell out of a punching bag ain't weak. And that's why I'm writing about this today. If my boxing classmates can have the strength to sweat through their tremors and wallop through their fears, then I can certainly have the strength to celebrate them without worrying what sort of light it casts on me. I'm proud to be one of them, and the purpose of this column is to reflect that pride and perhaps make it easier for other folks afflicted with Parkinson's to come out swinging. Officially, Parkinson's is a neurodegenerative disease impacting both motor and non-motor systems. Translated, the brain slowly stops producing dopamine, which is crucial for movement, and the loss of this neuro-transmitter affects everything from your stride to your speech. Roughly one million people in the United States have it, and there's no cure for it, and it generally gets worse as one gets older. As Michael J. Fox himself once said, it's the gift that keeps on taking. You don't die from it, but it can be hard to live with it, yet there is one thing that unquestionably helps slow its progression. Exercise. Movement. Pull your achy body off the couch every day and work those quivering muscles, stretch those tight joints, perhaps join one of the many Parkinson's programs in town that involve everything from dancing to hiking. 'For people living with Parkinson's disease, regular exercise can reduce symptoms, help treatments work better and potentially even slow the disease progression,' Rachel Dolhun, principal medical advisor at the Michael J. Fox Foundation, wrote in an e-mail. 'For some, exercise can look like participating in boxing classes. For others, it's water aerobics, dancing or playing pickleball. Just remember that any type of and amount of exercise can positively support your journey.' If you're like me and you just want to punch Parky in the face, boxing works best. The 83 tough souls who t pay $179 a month to battle in the Kaizen Kinetics program agree. 'I hit the bag really hard like I'm hitting Parkinson's,' said Rich Pumilia, 66, a lawyer from Monrovia. 'Hitting it back for what it's doing to me.' I became aware of Jody Hould's program, which she leads with the help of husband Tom, son Zac and Anthony Rutherford, shortly after I was diagnosed. I kept seeing their pamphlets in doctors offices and rehab centers. At the time, they were part of the popular Parkinson's-battling Rock Steady Boxing program that has several locations through southern California. By the time I worked up the courage to fully face my illness and call the number on the pamphlet two years ago, Kaizen had become an independent program with a similar focus on boxing. 'Boxing is balancing, posture, turning, pivoting, extension, range of motion, using your core, everything that's important to fighting the disease,' said Hould, who started the program nine years ago in memory of her late mother, Julie, who died of complications from Parkinson's. 'Plus, it's fun to punch something.' Hould and her team run a fast-moving program, barking out a series of punches and kicks while offering gentle reminders to those who hook when they should jab. 'Parkinson's doesn't take any vacations, it doesn't take any days off, we have to be on top of our game, we have to be proactive in our fight,' Hould said. 'Not only is it good for the spirit, it's good for the mind.' But it can be tough on the ego, as I quickly learned when a frail white-haired woman out-punched me one day while screaming at the bag. Another time an aging man with tremors and shuffled steps pounded the bag so hard it skidded into my feet. I once showed up with a cut on my left hand and informed Hould that I would not be boxing that day. 'You still have your right hand, don't you?' she said. 'So you box one-handed.' The 75-minute sessions are hard. Every exercise and maneuver are seemingly designed to do something I now have difficulty doing. Sometimes it hurts. Sometimes you want to be anywhere else. But it works. It can't kill Parky, but it can quiet him. Hould never promises a cure, but she sees some relief in those who join the battle. There was one boxer who eventually abandoned her walker. Others have seen a reduction in their tremors. Throughout the windowless gym there is real hope that this disease can be slowed. Pumilia is convinced his condition has improved after attending classes for eight weeks. 'When I was diagnosed, my doctor said you have five good years left before your life is going to be impacted,' said Pumilia. 'Now my doctor is basically saying, 'I don't know what you're doing, but keep doing it.'' Sharon Michaud, 65, a retired insurance executive who has also come to class for eight years, agrees. 'Without a doubt, it's helped me,' said Michaud, who is noticeable in the class because she moves like a gymnast. 'With Parkinson's it's easy to get into a funk and get depressed. You come here and it's nice to know there are other people like you. I'm amazed more people don't know there's places like this out here.' Maybe this story will shed some light on that. Maybe this story will inform a closeted Parkinson's patient about programs like Kaizen Kinetics and empower them to pick up the phone and join. If you decide to come to Monrovia, I'll be the breathless guy in the back still unable to deliver a knockout punch but continually inspired by fellow fighters to keep trading blows with my hardest of truths. I leave that gym sweaty and sore but uplifted with the reminder that I am blessed to still lead a wonderful active life filled with family and friends and work and travel and so, so much hope. I have Parkinson's. But, by God, it doesn't have me.
